Back to Journals » Therapeutics and Clinical Risk Management
Therapeutics and Clinical Risk Management
Editor-in-Chief: Professor Garry Walsh
ISSN 1176-6336 (Print) - went to online only in 2009
An international, peer-reviewed open access journal of clinical therapeutics and risk management, focusing on concise rapid reporting of clinical studies in all therapeutic areas, outcomes, safety, and programs for the effective, safe, and sustained use of medicines, therapeutic and surgical interventions in all clinical areas.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
This journal offers Accelerated Publication.
Articles:
- View all (2619)
- Volume 22, 2026 (63)
- Volume 21, 2025 (162)
- Volume 20, 2024 (86)
- Volume 19, 2023 (91)
- Volume 18, 2022 (104)
- Volume 17, 2021 (134)
- Volume 16, 2020 (134)
- Volume 15, 2019 (154)
- Volume 14, 2018 (271)
- Volume 13, 2017 (188)
- Volume 12, 2016 (217)
- Volume 11, 2015 (210)
- Volume 10, 2014 (113)
- Volume 9, 2013 (57)
- Volume 8, 2012 (47)
- Volume 7, 2011 (59)
- Volume 6, 2010 (66)
- Volume 5, 2009 (102)
- Volume 4, 2008 (148)
- Volume 3, 2007 (126)
- Volume 2, 2006 (47)
- Volume 1, 2005 (40)
Latest articles:
- 5 records -
Effectiveness of CYP2C19 Genotype-Guided Antiplatelet Therapy Following Neurovascular Endovascular Procedures: A Prospective Non-Randomized Controlled Study
Xu S, Wang X, Cui G, Li M, Chen G, Hu J, Zhang Q
Therapeutics and Clinical Risk Management 2026, 22:615918
Published Date: 9 July 2026
A Multi-Disciplinary Approach to the Management of Chemotherapy-Induced Nausea and Vomiting in Breast Cancer
Chen F, Cao K, Zhao X, Xia L, Liu M, Jiang Y
Therapeutics and Clinical Risk Management 2026, 22:620981
Published Date: 9 July 2026
Median Effective Dose of Esketamine Combined with Remifentanil for Anesthesia Induction in Painless Colonoscopy
Cao Z, Xue H, Wang H, Liu X
Therapeutics and Clinical Risk Management 2026, 22:584512
Published Date: 9 July 2026
Immune Checkpoint Inhibitors in Breast Cancer: Mechanisms, Biomarkers, and Future Therapeutic Strategies
Deng QC, Kuang WB, Yang YJ, Gong CP, Zhang YP, Luo Q, Luo LP, Wang GM
Therapeutics and Clinical Risk Management 2026, 22:547154
Published Date: 9 July 2026
Clinical Outcomes and Treatment-Related Complications in Triple-Negative Breast Cancer: A Review of 24 Case Reports from 2020 to 2025
Febriyanti RM, Hakim MLN, Rofiidatul I, Islami MS, Utami PS, Qurrotuaini SP, Halimah E, Mohd Hashim N, Diantini A
Therapeutics and Clinical Risk Management 2026, 22:619823
Published Date: 30 June 2026